In early March, HC Wainwright issued updated earnings forecasts for several biotech and pharmaceutical firms, raising estimates for NRx Pharmaceuticals and Nuvalent while lowering them for Senseonics, Nuvation Bio, and Aldeyra Therapeutics. Separately, Sidoti increased its Q1 2026 earnings estimate for Gibraltar Industries.
Comments